Pamela Fisher was named chief diversity and inclusion officer for Bristol-Myers Squibb, according to a Tuesday announcement.
Fisher joins BMS from New Brunswick-based Johnson & Johnson, where she served as head of diversity, equity & inclusion global strategy and partnerships.
Fisher will drive BMS’ Global Diversity & Inclusion business strategy, including advancing the company’s five core diversity commitments. She will be a member of CEO Giovanni Caforio’s leadership team.
“As a science leader, we have seen firsthand how diversity of thought, experience and background drive innovation that transforms patients’ lives. Pam is joining our company as we make progress on our commitment to increase health equity, further strengthen our diversity and shape our culture of inclusion,” Caforio said in a prepared statement.
Fisher brings over 20 years of experience in diversity and inclusion, along with global strategy, partnerships, philanthropy, government relations and business growth. Most recently at J&J, she led the launch of an evidence-based D&I strategy that helped grow the business by reaching diverse and multicultural patients and consumers.
Fisher also worked to increase diverse workforce representation and improve workforce engagement and sentiment on inclusion. She has broad and deep experience, is a respected leader in D&I and will bring a new perspective and momentum to the company’s D&I efforts.
“BMS is a company that understands the value and impact of having a workforce which reflects the patients and communities we serve and a culture of inclusion and belonging where everyone’s unique perspectives can collectively drive greater innovation and health care solutions. That’s why I am excited to join the BMS team to continue advancing our D&I strategy, addressing the evolving needs of patients and driving more equitable and sustainable health outcomes around the world,” Fisher stated.
